JP2004524813A - 改良された条件付けで複製するベクター類、それらの生成及び使用方法 - Google Patents
改良された条件付けで複製するベクター類、それらの生成及び使用方法 Download PDFInfo
- Publication number
- JP2004524813A JP2004524813A JP2002529492A JP2002529492A JP2004524813A JP 2004524813 A JP2004524813 A JP 2004524813A JP 2002529492 A JP2002529492 A JP 2002529492A JP 2002529492 A JP2002529492 A JP 2002529492A JP 2004524813 A JP2004524813 A JP 2004524813A
- Authority
- JP
- Japan
- Prior art keywords
- vector
- hiv
- cells
- helper
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/40—Vector systems having a special element relevant for transcription being an insulator
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/44—Vectors comprising a special translation-regulating system being a specific part of the splice mechanism, e.g. donor, acceptor
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66789300A | 2000-09-22 | 2000-09-22 | |
PCT/US2001/029976 WO2002024897A2 (fr) | 2000-09-22 | 2001-09-21 | Vecteurs ameliores a replication conditionnelle, procedes de production et utilisation de ces vecteurs |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004524813A true JP2004524813A (ja) | 2004-08-19 |
Family
ID=24680093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002529492A Pending JP2004524813A (ja) | 2000-09-22 | 2001-09-21 | 改良された条件付けで複製するベクター類、それらの生成及び使用方法 |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1356070A2 (fr) |
JP (1) | JP2004524813A (fr) |
AU (1) | AU9307501A (fr) |
CA (1) | CA2422544A1 (fr) |
CZ (1) | CZ2003784A3 (fr) |
IL (1) | IL154987A0 (fr) |
NO (1) | NO20031293L (fr) |
NZ (1) | NZ525283A (fr) |
RU (1) | RU2301260C2 (fr) |
WO (1) | WO2002024897A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002059378A2 (fr) | 2001-01-25 | 2002-08-01 | Virxsys | Procedes et compositions servant a identifier la fonction d'un gene |
US20030026791A1 (en) * | 2001-03-27 | 2003-02-06 | Laurent Humeau | Conditionally replicating vectors for inhibiting viral infections |
US20050196381A1 (en) * | 2003-09-09 | 2005-09-08 | Xiaobin Lu | Lentivirus vector-based approaches for generating an immune response to HIV in humans |
FR2872170B1 (fr) * | 2004-06-25 | 2006-11-10 | Centre Nat Rech Scient Cnrse | Lentivirus non interactif et non replicatif, preparation et utilisations |
AU2010329551B2 (en) | 2009-12-10 | 2016-02-11 | Turnstone Limited Partnership | Oncolytic rhabdovirus |
RS60207B1 (sr) * | 2011-04-22 | 2020-06-30 | Univ California | Adeno-povezani virioni virusa sa varijantama kapsida i postupci za njihovu primenu |
EP2718427B1 (fr) | 2011-06-08 | 2017-01-11 | Children's Hospital of Eastern Ontario Research Institute Inc. | Compositions pour le traitement du glioblastome |
JP2014528729A (ja) * | 2011-10-05 | 2014-10-30 | モルメド エスピーエー | ウイルスベクター精製システム |
RU2488633C1 (ru) * | 2011-11-16 | 2013-07-27 | Общество с ограниченной ответственностью "Лаборатория медицинской биотехнологии" (ООО "ЛМБТ") | ЭКСПРЕССИОННЫЙ ПЛАЗМИДНЫЙ ВЕКТОР ДЛЯ ГЕТЕРОЛОГИЧНОЙ ЭКСПРЕССИИ РЕКОМБИНАНТНЫХ БЕЛКОВ, ВЫСОКОЧАСТОТНОЙ ИНТЕГРАЦИИ И УСИЛЕННОЙ АМПЛИФИКАЦИИ ЭКСПРЕССИОННОЙ КАССЕТЫ В КЛЕТКАХ МЛЕКОПИТАЮЩИХ, БИЦИСТРОННАЯ мРНК, СПОСОБ ПОЛУЧЕНИЯ СТАБИЛЬНЫХ ЛИНИЙ ПРОДУЦЕНТОВ РЕКОМБИНАНТНЫХ БЕЛКОВ С ИСПОЛЬЗОВАНИЕМ УКАЗАННОГО ВЕКТОРА, СПОСОБ ПОЛУЧЕНИЯ РЕКОМБИНАНТНЫХ БЕЛКОВ |
WO2014089668A1 (fr) * | 2012-12-12 | 2014-06-19 | Children's Hospital Of Eastern Ontario Research Institute Inc. | Compositions et procédés permettant de traiter les cancers du cerveau |
ES2741147T3 (es) | 2013-02-21 | 2020-02-10 | Turnstone Lp | Composición de vacuna |
RU2548816C1 (ru) * | 2013-12-16 | 2015-04-20 | Мамонтова Марина Васильевна | Способ выделения микрорнк из биологических жидкостей |
CN109476707B (zh) | 2016-05-13 | 2022-12-02 | 4D分子治疗有限公司 | 腺相关病毒变体衣壳和其使用方法 |
KR20220124817A (ko) | 2017-08-07 | 2022-09-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 안전한 세포 치료제를 생성하기 위한 플랫폼 |
CN114174513A (zh) * | 2019-07-23 | 2022-03-11 | 牛津生物医学(英国)有限公司 | 慢病毒载体的优化生产 |
WO2022066937A1 (fr) * | 2020-09-23 | 2022-03-31 | Regents Of The University Of Minnesota | Kératinocytes immortalisés, lentivirus pour immortalisation de kératinocytes, et procédés d'utilisation |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000503527A (ja) * | 1995-11-28 | 2000-03-28 | ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン | 条件付き複製ウイルスベクターおよびその用途 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9803351D0 (en) * | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
-
2001
- 2001-09-21 EP EP01973503A patent/EP1356070A2/fr not_active Withdrawn
- 2001-09-21 NZ NZ525283A patent/NZ525283A/en not_active IP Right Cessation
- 2001-09-21 CZ CZ2003784A patent/CZ2003784A3/cs unknown
- 2001-09-21 RU RU2003111469/13A patent/RU2301260C2/ru not_active IP Right Cessation
- 2001-09-21 CA CA002422544A patent/CA2422544A1/fr not_active Abandoned
- 2001-09-21 AU AU9307501A patent/AU9307501A/xx not_active Withdrawn
- 2001-09-21 JP JP2002529492A patent/JP2004524813A/ja active Pending
- 2001-09-21 IL IL15498701A patent/IL154987A0/xx unknown
- 2001-09-21 WO PCT/US2001/029976 patent/WO2002024897A2/fr active IP Right Grant
-
2003
- 2003-03-20 NO NO20031293A patent/NO20031293L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000503527A (ja) * | 1995-11-28 | 2000-03-28 | ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン | 条件付き複製ウイルスベクターおよびその用途 |
Also Published As
Publication number | Publication date |
---|---|
CA2422544A1 (fr) | 2002-03-28 |
WO2002024897A2 (fr) | 2002-03-28 |
WO2002024897A3 (fr) | 2003-07-31 |
IL154987A0 (en) | 2003-10-31 |
EP1356070A2 (fr) | 2003-10-29 |
RU2301260C2 (ru) | 2007-06-20 |
CZ2003784A3 (cs) | 2003-11-12 |
NO20031293D0 (no) | 2003-03-20 |
WO2002024897A9 (fr) | 2003-03-20 |
NZ525283A (en) | 2008-06-30 |
AU9307501A (en) | 2002-04-02 |
NO20031293L (no) | 2003-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6410257B1 (en) | Methods to assay gene function with viral vectors | |
JP4384146B2 (ja) | 条件付き複製ウイルスベクターおよびその用途 | |
JP2004524813A (ja) | 改良された条件付けで複製するベクター類、それらの生成及び使用方法 | |
US20030026791A1 (en) | Conditionally replicating vectors for inhibiting viral infections | |
US5885806A (en) | Methods to prepare conditionally replicating viral vectors | |
US7803582B2 (en) | Recombinant vector and use in gene therapy | |
AU2001293075B2 (en) | Conditionally replicating viral vectors and their use | |
US20120034693A1 (en) | Recombinant vector and use in gene therapy | |
AU2001293075A1 (en) | Conditionally replicating viral vectors and their use | |
AU2002258639A1 (en) | Improved conditionally replicating vectors for inhibiting viral infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080801 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110412 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20111025 |